Chemoinformaics analysis of (3S)-10,10-DIMETHYL-2,6-DIMETHYLIDENEBICYCLO[7.2.0]UNDECAN-3-OL
| Molecular Weight | 220.356 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 1 |
| Exact Molecular Weight | 220.183 | nRing | 2 |
| Solubility: LogS | -6.974 | nHRing | 0 |
| Solubility: LogP | 10.036 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.14 |
| Synth | 1.75 |
| Natural Product Likeliness | 0.555 |
| NR-PPAR-gamma | 0.3 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -5.167 |
| MDCK | 0.00000603 |
| BBB | 0.019 |
| PPB | 0.984446 |
| VDSS | 4.443 |
| FU | 0.00941747 |
| CYP1A2-inh | 0.068 |
| CYP1A2-sub | 0.154 |
| CYP2c19-inh | 0.175 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.043 |
| CYP2c9-sub | 0.965 |
| CYP2d6-inh | 0.469 |
| CYP2d6-sub | 0.047 |
| CYP3a4-inh | 0.187 |
| CYP3a4-sub | 0.019 |
| CL | 3.928 |
| T12 | 0.035 |
| hERG | 0.59 |
| Ames | 0.014 |
| ROA | 0.01 |
| SkinSen | 0.985 |
| Carcinogencity | 0.046 |
| EI | 0.93 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.134 |
| Antiviral | Yes |
| Prediction | 0.883715 |